From February 9, 2024 to March 6, 2024, the company has repurchased 5,970,149 shares, representing 0.59% for INR 6,000 million. With this, the company has completed the repurchase of 5,970,149 shares, representing 0.59% for INR 6,000 million under the buyback announced on February 9, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
968.2 INR | -3.72% | +1.54% | +40.48% |
May. 09 | Zydus Lifesciences Gets US FDA Final Nod for Acne Treatment Gel | MT |
May. 09 | Zydus Lifesciences Limited Receives Final Approval from USFDA for Dapsone Gel, 7.5% | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.48% | 12.12B | |
+18.67% | 43.74B | |
+23.56% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
-9.16% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B | |
+9.14% | 4.83B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Tranche Update on Zydus Lifesciences Limited's Equity Buyback Plan announced on February 9, 2024.